Subcutaneous Injection Technique Protocol
Detailed protocol for performing subcutaneous peptide injections in research settings, covering site selection, proper technique, aseptic procedure, and post-injection care.
Materials Needed
- Reconstituted peptide solution (verified concentration)
- Insulin syringe (U-100, 29-31 gauge needle)
- Alcohol swabs (70% isopropyl)
- Sharps disposal container
- Powder-free nitrile gloves
- Adhesive bandage (optional)
Verify Dose and Prepare Materials
Confirm your calculated dose using the Dosing Calculation Protocol. Gather all materials on a clean surface. Verify the peptide solution is clear, colorless, and free of particulate matter. Check the reconstitution date to ensure the solution is within its stability window.
Tips
- • Never administer a solution that appears cloudy, discolored, or contains particles
- • Have a sharps container within arm's reach before beginning
Wash Hands and Don Gloves
Thoroughly wash hands with soap and water for at least 20 seconds. Dry with a clean towel. Put on powder-free nitrile gloves. Good hand hygiene is the single most important step in preventing infection.
Estimated time: 2 minutes
Draw the Dose
Swab the peptide vial stopper with alcohol and allow to dry. Draw the calculated dose using the technique described in the Dosing Calculation Protocol. Verify the volume at eye level. Tap out air bubbles and express a tiny drop from the needle tip to confirm air-free delivery.
Estimated time: 2 minutes
Verify the dose volume twice before proceeding
Select and Prepare the Injection Site
Common subcutaneous injection sites include the abdominal area (avoiding a 2-inch radius around the navel), the front of the thigh (middle third), and the back of the upper arm. Rotate injection sites to prevent lipodystrophy. Clean the selected site with an alcohol swab using a circular motion from center outward. Allow the alcohol to dry completely.
Estimated time: 1 minute
Never inject into bruised, scarred, or inflamed skin
Rotate injection sites with each administration
Tips
- • The abdomen generally provides the most consistent absorption for most peptides
- • Keep a log of injection sites to ensure proper rotation
Perform the Injection
With your non-dominant hand, pinch a fold of skin at the injection site. Hold the syringe like a pencil in your dominant hand. Insert the needle at a 45-90 degree angle (45 degrees for lean individuals, 90 degrees if there is adequate subcutaneous tissue). Insert the needle fully to the hub. Release the skin pinch, then slowly and steadily depress the plunger to deliver the full dose.
Estimated time: 1 minute
Do not aspirate (pull back on the plunger) — this is no longer recommended for subcutaneous injections
Inject slowly to minimize tissue trauma and discomfort
Tips
- • A 45-degree angle is appropriate for most injection sites and body compositions
- • Slow, steady injection (over 5-10 seconds) is more comfortable than rapid injection
Withdraw and Apply Pressure
After delivering the full dose, hold the syringe in place for 5 seconds. Withdraw the needle at the same angle it was inserted. Immediately apply gentle pressure with a clean alcohol swab or gauze. Do not rub the injection site — this can cause bruising and may affect absorption.
Estimated time: 1 minute
Do not rub the injection site after withdrawal
A small drop of blood at the site is normal — apply gentle pressure
Dispose and Document
Immediately place the used syringe and needle (do not recap) into the sharps disposal container. Record the injection in your research log: date, time, peptide, dose, injection site, and any observations. Apply an adhesive bandage if desired.
Never recap a used needle — this is the most common cause of needlestick injuries
Never dispose of syringes in regular trash
Related Monographs
BPC-157
An in-depth review of Body Protection Compound-157, covering its mechanism of action, research applications in tissue repair, gut health, and neuroprotection, along with key published studies.
Read monographTB-500
A comprehensive review of TB-500, a synthetic fragment of Thymosin Beta-4, examining its role in wound healing, tissue regeneration, and inflammation research.
Read monographIpamorelin
An in-depth review of Ipamorelin, a highly selective growth hormone secretagogue pentapeptide, covering its mechanism of action, pharmacokinetics, research applications in GH release, bone density, muscle growth, and safety profile.
Read monographSermorelin
An in-depth review of Sermorelin (GHRH 1-29), a growth hormone-releasing hormone analog, covering its mechanism of action, pharmacokinetics, safety profile, research applications in GH stimulation, anti-aging, and pituitary function preservation.
Read monographSemaglutide
An in-depth review of Semaglutide, a long-acting GLP-1 receptor agonist, covering its mechanism of action, albumin-binding pharmacokinetics, and research applications in metabolic health, weight management, and cardiovascular outcomes.
Read monographTirzepatide
An in-depth review of Tirzepatide, the first dual GIP/GLP-1 receptor agonist ('twincretin'), examining its mechanism of action, superior glycemic and weight loss efficacy, and research applications in metabolic health.
Read monographRelated Protocols
Bacteriostatic Water Handling Protocol
Complete guide to proper handling, storage, and use of bacteriostatic water for peptide reconstitution, including quality verification, contamination prevention, and shelf-life management.
GLP-1 Receptor Agonist Research Protocol
Research protocol for GLP-1 receptor agonist peptides including Semaglutide, Tirzepatide, and Retatrutide, covering dose titration schedules, reconstitution specifics, and monitoring considerations from published clinical research.
GHRP + GHRH Combination Protocol
Research protocol for combining growth hormone-releasing peptide (GHRP) with growth hormone-releasing hormone (GHRH) analogs to achieve synergistic GH release, including timing, dosing rationale, and monitoring considerations.
BPC-157 + TB-500 Healing Combination Protocol
Research protocol for combining BPC-157 and TB-500 (Thymosin Beta-4) for synergistic tissue healing research, covering dosing rationale, administration timing, and the complementary mechanisms of these two healing peptides.